Pelvic Floor Diagnostics Market Snapshot
As per newly released data by Future Market Insights Market, the global demand for l pelvic floor diagnostics market will increase at a year-on-year (YoY) growth of 7.0% in 2021.
Overall valuation of the pelvic floor diagnostics market will total US$ 1,823.6 Mn for 2021, and it is expected to rise at a 6.2% CAGR through the end of the assessment period in 2031.
The report also forecasts the demand for uroflowmetry devices and anal manometry systems are expected to rise at 8.2% CAGR through the assessment period.
Key Points Covered in the Pelvic Floor Diagnostics Market
- Market estimates and forecast 2016-2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Pelvic Floor Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
2016-2020 Pelvic Floor Diagnostics Market Outlook Compared to 2021-2031 Forecast
The pelvic floor diagnostics market is expected to rise at a CAGR of 6.2% between 2021 and 2031 in comparison to the 3.5% CAGR registered during 2016-2020. This growth is highly associated with factors such as growing healthcare expenditure and the rising number of technology advancements in the pelvic floor diagnostic sectors.
The prevalence of pelvic floor disorders especially among pregnant women and growing awareness for early diagnosis have further propelled sales of pelvic floor diagnostics systems. Growing research and development activities in the field have been supported by financial grants through key players and have led to innovative breakthroughs in disease control.
Rising awareness among women and men about early diagnosis has led to increased set up of diagnostic imaging centers. There is a surge in demand for ultrasound imaging systems for high-resolution imaging over the radiological methods.
The rise in healthcare spending and growing funding associated with favorable reimbursement has led manufacturers to invest in medical devices. This has resulted in increased adoption of pelvic floor diagnostics along with the growth of other associated markets such to treat pelvic floor prolapse and other dysfunctions.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What Factors Drive Pelvic Floor Diagnostics Market?
The growth of the pelvic floor diagnostics market is primarily associated with the growing prevalence of pelvic floor disorders globally and rising healthcare expenditure. The developments of technologically advanced diagnostic systems along with government support has led to a surge in demand for reliable and extensive diagnostic systems.
Improvements in reimbursement structures has led manufacturers to invest in the pelvic floor diagnostic sector creating a conducive environment for growth through 2031.
What is the Impact of the COVID-19 Crisis on Pelvic Floor Diagnostics?
The pandemic has worsened patient waiting times across the world. Significant reduction in the physicians’ office and diagnostic center visits and the subsequent decline in the number of prescription and pre-prescribed medication is expected to hamper market growth during COVID-19 crisis.
The availability of the COVID-19 vaccine nation-wide and speedy vaccination programs are expected to aid market recovery in the coming years. New device launches are expected to hamper growth with short-term disruptions in the supply chain, delaying pipeline research and development and changing the priority of leading healthcare companies to combat the COVID-19 outbreak. Thus, the pandemic negatively impacted the growth of the pelvic floor diagnostics market.
How is the Pelvic Floor Diagnostics Market Faring in the U.S.?
The U.S. dominates the market for pelvic floor diagnostics and is expected to witness steady growth during the forecast period according to Future Market Insights. The analysis estimates that the U.S. will account for a market share of 81.5% in North America in 2021.
The growth of pelvic floor diagnostics market in the country is characterized by the rising prevalence rate of pelvic floor disorders among pregnant women and the subsequent rise in healthcare expenditure.
Why is the Demand for Pelvic Floor Diagnostics Increasing in the U.K.?
The U.K pelvic floor diagnostics market is expected to witness a CAGR of 5.8% over the forecast period. Government support and funding’s has promoted demand. Rapid increase in the geriatric population is a primary factor leading to an increase in pelvic floor disorders.
According to estimates conducted by the UNU (United Nations University), the percentage of geriatrics above 65 years of age is expected to rise up to 16% by 2050 from 7% in 2000. A study conducted in 2005 by the World Health Organization determined that one of the major factors leading to urinary incontinence in women is ageing, which will also support sales prospects.
What is the Outlook of the Brazil Pelvic Floor Diagnostics Market?
Brazil holds a current market share of 48.9% of the revenue generated in Latin America in 2020. According to the analysis by Future Market Insights, the country is expected to present highly lucrative growth with a CAGR of 5.5% over the forecast period.
Brazil is expected to support profitable growth due to the increasing prevalence of pelvic floor disorders such as overactive bladders and urinary incontinence among females. In Brazil, estimates of the prevalence of OAB range from 7.6% to 25% and the rise in government regulations for its treatment.
The use of diagnostic devices and in-clinic diagnostic procedures for pelvic floor diagnosis has seen a proportionate increase along with the rising adoption rates by high-income population groups. The demand for hospitals and diagnostic laboratories for pelvic floor diagnosis has led to growth in the country.
What are the Prospects of Pelvic floor Diagnostics in Mexico?
In 2020, Mexico accounted for over 38.4% of market share, in Latin America. The moderately steady growth in the country is influenced by the growing demand of various pelvic floor diagnostic testing services.
Pelvic floor diagnosis has been hindered by the topic being considered taboo. Increasing expenditure and growing awareness programs by the government to support the population has led to a rise in the demand of pelvic floor diagnostics in Mexico.
Why are Ultrasound Systems Key to Revenue Generation?
The demand for ultrasound systems in the pelvic floor diagnostics market globally is supported by the demand for ultrasound systems over radiological methods. Ultrasound systems amount to the largest market share of 37.3% as of 2020 and are expected to grow over the forecast period at a CAGR of 5.7%.
The growing advancements in the ultrasound systems has triggered a renewed interest in diagnostic imaging in urogynecology and female urology.
What is the Contribution of Hospitals to Pelvic Floor Diagnostics Sales?
Based on the end-user, the hospitals segment depicts the highest market share of 64.2% in the year 2021, and is projected to grow at a CAGR of 5.5% over the forecast period.
The revenue growth of the hospital segment is projected to account for over US$ 2,002.0 Mn by the end of the forecast period. The growth is supported by improving health infrastructure, increasing number of experienced physicians, availability of advanced devices, and rising research and development (R&D) spending for medical devices.
Key players operating in the pelvic floor diagnostics market are involved in innovative research and development activities for specialized and efficient diagnostic devices. Major companies also focus on strategic of mergers and acquisitions for geographical expansion and increased market footprint.
- For instance, in March 2021, HOYA Corporation (the parent company of Albyn Medical) signed a five-year contract for technical collaboration and supply of diagnostics ultrasound systems and ultrasound sensor with Hitachi.
- In June 2021, Neusoft Corporation revealed its portfolio of medical imaging for diagnosis including its NeuAngio 30F high speed floor-mounted DSA system.
- In April 2021, Analytica Ltd. entered a joint venture with Shijiazhuang Biosphere Pty Ltd. and Hebei Nacol Bio-Technology Co. Ltd. for the production and distribution of its Pericoach urinary incontinence device.
Scope of Report
Historical Data Available for
USD Million for Value and Volume in ‘000’ Units
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa
Key Countries Covered
US, Canada, Brazil, Mexico, U.K., Germany, France, Spain, Italy, Russia, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, Oceania, GCC Countries, South Africa, Turkey
Key Segments Covered
Product and End User
Key Companies Profiled
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Key Questions Answered in the Report
What is the pelvic floor diagnostics market worth?
The global pelvic floor diagnostics market is expected to surpass US$ 1.8 Bn in 2021.
What is the share of the top players in the pelvic floor diagnostics market in 2021?
GlaxoSmithKline Plc, Sanofi, Johnson & Johnson, and Pfizer cumulatively account for 25-30% of the market.
Which are the top 5 countries driving demand for pelvic floor diagnostics?
The U.S., Canada, India, China, and Japan consistently reflect high demand for pelvic floor diagnostics services.
Which countries are key service providers of pelvic floor diagnostics?
The U.S., Canada, India, China, and Japan are the leading service providers for pelvic floor diagnostics services.
What factors drive the demand for pelvic floor diagnostics?
Expansion of the global geriatric demographic, urinary incontinence among pregnant women, and awareness campaigns for treatment options are likely to drive growth.
What were the global pelvic floor diagnostics market growth statistics between 2020 and 2021?
The pelvic floor diagnostics market grew by 7.4% between 2020 and 2021.
At what rate did the pelvic floor diagnostics market grow in the last 5 years?
The market rose at a 4.6% CAGR from 2016 to 2020
What is the North America pelvic floor diagnostics market outlook?
The market in North America is projected to rise at a 7.6% CAGR through 2031.
At what rate is the sales of pelvic floor diagnostic services expected to rise in Europe?
The Europe pelvic floor diagnostics market is set to rise at a 7.8% CAGR through the assessment period.
What are the key statistics of the South Korea and Japan pelvic floor diagnostics market?
In 2020, Japan and South Korea accounted for share of 32% and 19% share respectively in East Asia region.
Pelvic Floor Diagnostics Market by Category
- Urodynamics Systems
- Uroflowmetry Devices
- Anal Manometry Systems
- Ultrasound Systems
- Cart/Trolley Based
- Portable Bladder Ultrasound Systems
By End User:
- Diagnostic Imaging Centers
- Specialty Clinics
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa